ML299
ML299 is a selective allosteric modulator and a dual inhibitor of phospholipases D1 and D2 (IC50 values are 6 and 12 nM, respectively) . ML299 decreases invasive migration in U87-MG glioblastoma cells[1].
Product Specifications
CAS Number
1426916-00-8
UNSPSC
12352005
Target
Phospholipase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ml299.html
Purity
99.46
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C(C=C1)Br)N[C@H](CN2CCC3(N(CNC3=O)C4=CC=CC(F)=C4)CC2)C
Molecular Formula
C23H26BrFN4O2
Molecular Weight
489.38
References & Citations
[1]O'Reilly MC, et al. Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1,3,8-Triazaspiro[4.5]decane Core: discovery of Ml298 and Ml299 that decrease invasive migration in U87-MG glioblastoma cells. J Med Chem. 2013 Mar 28;56 (6) :2695-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
302852-HRP 200 µL
ZBTB8A (Zinc Finger and BTB Domain-Containing Protein 8A, BTB/POZ and Zinc-Finger Domain-Containing Factor, BTB/POZ and Zinc-Finger Domains Factor on Chromosome 1, BOZ-F1, ZBTB8A, BOZF1) (HRP) discontinued
Sign In for Pricing
View Details 
